Moderna files for FDA authorization of its Covid-19 Vaccine
Supply readiness follows months of manufacturing to ensure timely and ample supply
Supply readiness follows months of manufacturing to ensure timely and ample supply
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
The company will submit its comprehensive response on these observations to the USFDA
Augnito’s AI comprehends all English accents with 99% accuracy
This product will be manufactured at Lupin's Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated